Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 157

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 1
Chunk 157
---
-gaap:CommercialPaperMember
      us-gaap:RelatedPartyMember

    2024-11-21

    0002028614
    
      us-gaap:CommercialPaperMember
      us-gaap:RelatedPartyMember

    2024-12-05

    0002028614
    
      us-gaap:CommercialPaperMember

    2024-03-23
    2024-12-31

    0002028614
    
      us-gaap:CommercialPaperMember
      dmaau:SponsorMember

    2024-03-23
    2024-12-31

    0002028614
    
      us-gaap:CommercialPaperMember

    2024-12-31

    0002028614
    
      us-gaap:CommercialPaperMember

    2025-06-30

    0002028614
    
      dmaau:CFOAgreementMember

    2025-04-01
    2025-06-30

    0002028614
    
      dmaau:CFOAgreementMember

    2025-01-01
    2025-06-30

    0002028614

    2024-01-01
    2024-12-30

    0002028614
    
      srt:ChiefFinancialOfficerMember

    2025-03-31

    0002028614
    
      srt:ChiefFinancialOfficerMember

    2024-12-31

    0002028614
    
      dmaau:RelatedPartyLoansMember

    2025-06-30

    0002028614
    
      dmaau:RelatedPartyLoansMember

    2024-12-31

    0002028614
    
      dmaau:SponsorMember

    2025-01-01
    2025-06-30

    0002028614
    
      us-gaap:OverAllotmentOptionMember

    2025-06-30

    0002028614
    
      dmaau:SubscriptionPromissoryNoteMember

    2025-06-30

    0002028614
    
      us-gaap:OverAllotmentOptionMember
      dmaau:UnderwritingAgreementMember

    2025-